BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Doummar D, Dentel C, Lyautey R, Metreau J, Keren B, Drouot N, Malherbe L, Bouilleret V, Courraud J, Valenti-Hirsch MP, Minotti L, Dozieres-Puyravel B, Bär S, Scholly J, Schaefer E, Nava C, Wirth T, Nasser H, de Salins M, de Saint Martin A, Warde MTA, Kahane P, Hirsch E, Anheim M, Friant S, Chelly J, Mignot C, Rudolf G. Biallelic PDE2A variants: a new cause of syndromic paroxysmal dyskinesia. Eur J Hum Genet 2020;28:1403-13. [PMID: 32467598 DOI: 10.1038/s41431-020-0641-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Scarduzio M, Hess EJ, Standaert DG, Eskow Jaunarajs KL. Striatal synaptic dysfunction in dystonia and levodopa-induced dyskinesia. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105650] [Reference Citation Analysis]
2 Erro R, Mencacci NE, Bhatia KP. The Emerging Role of Phosphodiesterases in Movement Disorders. Mov Disord 2021. [PMID: 34155691 DOI: 10.1002/mds.28686] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Zhang ZX, Han Q, Liu SY. Clinical significance of PDE2A in prognosis and immune infiltration in gastrointestinal cancer based on bioinformatics analysis. Shijie Huaren Xiaohua Zazhi 2021; 29(18): 1055-1063 [DOI: 10.11569/wcjd.v29.i18.1055] [Reference Citation Analysis]
4 Harvey S, King MD, Gorman KM. Paroxysmal Movement Disorders. Front Neurol 2021;12:659064. [PMID: 34177764 DOI: 10.3389/fneur.2021.659064] [Reference Citation Analysis]
5 Liao JY, Salles PA, Shuaib UA, Fernandez HH. Genetic updates on paroxysmal dyskinesias. J Neural Transm (Vienna) 2021;128:447-71. [PMID: 33929620 DOI: 10.1007/s00702-021-02335-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Schiavi S, Carbone E, Melancia F, di Masi A, Jarjat M, Brau F, Cardarelli S, Giorgi M, Bardoni B, Trezza V. Phosphodiesterase 2A inhibition corrects the aberrant behavioral traits observed in genetic and environmental preclinical models of Autism Spectrum Disorder. Transl Psychiatry 2022;12:119. [PMID: 35338117 DOI: 10.1038/s41398-022-01885-2] [Reference Citation Analysis]
7 Delorme C, Giron C, Bendetowicz D, Méneret A, Mariani LL, Roze E. Current challenges in the pathophysiology, diagnosis, and treatment of paroxysmal movement disorders. Expert Rev Neurother 2021;21:81-97. [PMID: 33089715 DOI: 10.1080/14737175.2021.1840978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Geng H, Chen X, Wang C. Systematic elucidation of the pharmacological mechanisms of Rhynchophylline for treating epilepsy via network pharmacology. BMC Complement Med Ther 2021;21:9. [PMID: 33407404 DOI: 10.1186/s12906-020-03178-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Girges C, Vijiaratnam N, Wirth T, Tjoakarfa C, Idaszak J, Seneviratne U. Seizures triggered by eating - A rare form of reflex epilepsy: A systematic review. Seizure 2020;83:21-31. [PMID: 33080481 DOI: 10.1016/j.seizure.2020.09.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
10 Gonzalez-latapi P, Marotta N, Mencacci NE. Emerging and converging molecular mechanisms in dystonia. J Neural Transm 2021;128:483-98. [DOI: 10.1007/s00702-020-02290-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]